Zomedica Stock Forecast for 2022 - 2025 - 2030

Updated on 05/19/2022

Stock Rating
0 / 10
Price Target
$0.00
Consensus
-
Downside
-100%
Analysts
0
Stock Rating
0
Downside
-100%
Analysts
0
Price Target
$0.00

Based on the current earnings figures, this year's price targets for Zomedica were recently set by zero distinguished experts, with an average mark of $0.00. If it reached this goal, it would represent a potential downside of approximately 0 from the previous closing price in January, 2022. The high end is $0.00, and the low is $0.00.

$0.00

N/A

-

Zomedica Price Forecast for 2022 - 2025 - 2030

Over the last three years, Zomedica's Price has increased by 100%, going from $0.00 to $0.00. In the next year, analysts are expecting a significant increase in EPS, predicting it will reach $0.31 – an increase of 100%. The 2030 forecast is for Price to reach $0.72 or grow by 100%.

2022 Price Forecast
$0.31
2023 Price Forecast
$0.34
2024 Price Forecast
$0.38
2025 Price Forecast
$0.43
2026 Price Forecast
$0.47
2027 Price Forecast
$0.53
2028 Price Forecast
$0.59
2029 Price Forecast
$0.65
2030 Price Forecast
$0.72
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts

Zomedica Revenue Forecast for 2022 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts

Zomedica Dividend per Share Forecast for 2022 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts

Zomedica Free Cash Flow Forecast for 2022 - 2025 - 2030

In the past three years, Zomedica's Free Cash Flow has significantly grown, increasing from $-11.78 to $-14.43 – a growth of 22.5%. The next year, 0 experts forecast that Zomedica's Free Cash Flow will decrease by 5.21%, reaching $-14.61. Over the next nine years, experts anticipate that ZOM's Free Cash Flow will grow at a rate of 1.24%.

2022 Free Cash Flow Forecast
$-13.68
2023 Free Cash Flow Forecast
$-14.37
2024 Free Cash Flow Forecast
$-15.01
2025 Free Cash Flow Forecast
$-14.83
2026 Free Cash Flow Forecast
$-14.44
2027 Free Cash Flow Forecast
$-14.43
2028 Free Cash Flow Forecast
$-14.62
2029 Free Cash Flow Forecast
$-14.69
2030 Free Cash Flow Forecast
$-14.61
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts

Zomedica Net Income Forecast for 2022 - 2025 - 2030

Zomedica's Net Income has increased by 10.39% in the last three years, going from $-16.65 to $-18.38. In the following year, the 0 analysts surveyed believe that ZOM's Net Income will decrease by 2.28%, reaching a dismal $-18.17. According to professionals, by 2030, Zomedica's Net Income will have decreased by 1.14%, falling all the way down to $-18.17.

2022 Net Income Forecast
$-17.96
2023 Net Income Forecast
$-18.64
2024 Net Income Forecast
$-18.06
2025 Net Income Forecast
$-18.18
2026 Net Income Forecast
$-18.11
2027 Net Income Forecast
$-18.29
2028 Net Income Forecast
$-18.21
2029 Net Income Forecast
$-18.20
2030 Net Income Forecast
$-18.17
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts

Zomedica EBITDA Forecast for 2022 - 2025 - 2030

In the last three years, Zomedica's EBITDA has grown by 23.58%, from $-16.37 to $-20.23. According to the 0 analysts polled, in the next year, ZOM's EBITDA will fall by 5.4%, reaching a lowly $-19.07. By 2030, professionals believe that Zomedica's EBITDA will have decreased by an astonishing 5.75%, plummeting to just $-19.07.

2022 EBITDA Forecast
$-19.14
2023 EBITDA Forecast
$-19.49
2024 EBITDA Forecast
$-18.54
2025 EBITDA Forecast
$-19.09
2026 EBITDA Forecast
$-19.12
2027 EBITDA Forecast
$-19.25
2028 EBITDA Forecast
$-19.01
2029 EBITDA Forecast
$-19.04
2030 EBITDA Forecast
$-19.07
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts

Zomedica EBIT Forecast for 2022 - 2025 - 2030

In the past three years, Zomedica's EBIT has seen a tremendous increase, going from $-16.58 to $-21.37 – an increase of 28.89%.

2022 EBIT Forecast
$-19.96
2023 EBIT Forecast
$-20.20
2024 EBIT Forecast
$-19.14
2025 EBIT Forecast
$-19.87
2026 EBIT Forecast
$-19.91
2027 EBIT Forecast
$-20.02
2028 EBIT Forecast
$-19.73
2029 EBIT Forecast
$-19.77
2030 EBIT Forecast
$-19.82
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts

Zomedica EPS Price Prediction Forecast for 2022 - 2025 - 2030

In the past three years, Zomedica's EPS has decreased by 72.22%, going from $-0.18 to only $-0.05. In the next year, analysts are expecting a significant increase in EPS, predicting it will reach $-0.10 – an increase of 91.58%. The 2030 forecast is for EPS to reach $-0.11 or grow by 125.86%.

2022 EPS Forecast
$-0.10
2023 EPS Forecast
$-0.17
2024 EPS Forecast
$-0.12
2025 EPS Forecast
$-0.10
2026 EPS Forecast
$-0.11
2027 EPS Forecast
$-0.13
2028 EPS Forecast
$-0.12
2029 EPS Forecast
$-0.12
2030 EPS Forecast
$-0.11
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts

© Copyright 2022 | Stock Forecast | All Rights Reserved